Synthon CEO Anish Mehta Shares His Leadership Playbook on the Active Ingredients Podcast 

Synthon CEO Anish Mehta joined Thomas Dove, host of Active Ingredients, the leadership series for people who build, scale and shape the future of life sciences. Together, they explored a wide-ranging conversation on what it takes to lead in generics pharmaceuticals today. 

Across the episode, Mehta traces a 25-plus year career that began on a factory floor milling antibiotic active ingredients and now spans engineering, strategy consulting, commercial leadership and private equity-backed CEO roles. He sets out the four qualities he believes define great leadership: strategic conviction, growth mindset, authenticity and stamina. Then he explains his philosophy on dealmaking, built around growing the size of the opportunity for both sides rather than negotiating who gets the bigger share. 

Mehta also speaks to Synthon's role in Europe's generics industry, the growing importance of security of supply and onshore manufacturing, and how new modalities and AI are reshaping the path medicines take from lab to patient. 

Listen to the full episode on the Active Ingredients podcast, available on their website or on your preferred podcast platform. 

Synthon is a Dutch-headquartered, privately owned pharmaceutical company specializing in the development, manufacturing, and commercialization of complex generic medicines. With more than 35 years of experience and manufacturing operations across Europe and Latin America, Synthon partners with pharmaceutical companies worldwide to bring high-quality, affordable medicines to patients.

For further information, please contact:
Synthon
Email: info@synthon.com
Tel: +31 24 372 77 00
Website: www.synthon.com